Insomnia Treatment Drugs Market : Worldwide Industry Analysis with Trends, Leading Players, Share, Size, and Forecast to 2026

The insomnia treatment drugs market is set to reach US$ 4,332.4 Mn by 2026 from US$ 2,689.6 Mn in 2017 highlighting balanced growth at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2018 to 2026.

The newest market report announced by Credence Research, Inc. “Global Insomnia Treatment Drugs Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global insomnia treatment drugs market was estimated at US$ 2,689.6 Mn in 2017, and is anticipated to hit US$ 4,332.4 Mn by 2026, growing at a CAGR of 5.5% from 2018 to 2026.

Browse the full report Insomnia Treatment Drugs Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/insomnia-treatment-drugs-market

Market Insights
As per the scientific evidence reported by American Psychiatric Association (APA) about one-third of the adults suffer with insomnia throughout their lifetime. It is manifested by incessant problems in falling and staying asleep. Patients undergoing with insomnia experience symptoms such as fatigue, mood disturbances, lack of concentration, low productivity, loss of appetite etc. Pharmaceutical companies are relentlessly working to provide effective medication with least side effects. Orexin antagonist (Belsomra) are being directed by physicians during the globe owing to its ability to improve sleep with the high degree of tolerability and limited adverse effects profile. The insomnia treatment drugs market pose a severe threat from alternative treatment such as cognitive behavioral therapy for insomnia (CBTI) and recent FDA approval of devices such as Fisher Wallace Stimulator and EBB Insomnia Therapy.

Market Synopsis
Rising health awareness about insomnia treatment to propel the prescription sleep aids market
As if now the prescription sleep aids are commanding the insomnia treatment drugs market. Physicians during the globe are prescribing benzodiazepines, antidepressant and orexin antagonist to patients suffering from sleep disorder. Benzodiazepine such as diazepam, alprazolam, and clonazepam are prescribed in patients suffering from insomnia due to anxiety. Antidepressant is given in combination with zolpidem (sedative) in patients suffering from insomnia due to neuropsychiatric ailment. The difficulties faced by prescription sleep aid drugs are the severe adverse effects associated with it such as withdrawal symptoms, psychosis and seizures. Over the counter sleep aids will be projecting excellent market growth during the projection period owing to growing popularity in developing countries, low cost and no adverse effects.

ToC:
F.Hoffman La-Roche AG, Merck & Co. Inc., Mylan N.V., Pfizer, Inc., Pernix Therapeutics, Sanofi S.A., Takeda Pharmaceutical Company Ltd., Sumitomo Dainippon Pharma Co., Ltd, Teva Pharmaceutical Industries Ltd. and Vanda Pharmaceuticals, Inc.

Increasing geriatric population suffering with insomnia to drive the insomnia treatment drugs market in Asia Pacific region
(For this segment view full report)

TOC:
Chapter 4. Global Insomnia Treatment Drugs Market, by Treatment Type
4.1. Overview
4.2. Prescription Sleep Aids
4.2.1. Benzodiazepine
4.2.2. Antidepressant
4.2.3. Orexin Antagonist
4.3. Over the Counter (OTC) Sleep Aids
4.3.1. Antihistamines
4.3.2. Melatonin
4.3.3. Dietary Supplement

Chapter 5. Global Insomnia Treatment Drugs Market, by Geography
5.1. Overview
5.2. North America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.2.1. North America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.2.2. North America Insomnia Treatment Drugs Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.3.1. Europe Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.3.2. Europe Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.4.1. Asia Pacific Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.5.1. Latin America Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.5.2. Latin America Insomnia Treatment Drugs Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa Insomnia Treatment Drugs Market Analysis, 2016 – 2026
5.6.1. MEA Insomnia Treatment Drugs Market, by Treatment Type, 2016 – 2026 (US$ Mn)
5.6.2. MEA Insomnia Treatment Drugs Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Browse the full report Insomnia Treatment Drugs Market - Growth, Future Prospects, Competitive Analysis, 2018 – 2026 report at https://www.credenceresearch.com/report/insomnia-treatment-drugs-market

About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.

Contact Info:
Name: Chris Smith
Email: Send Email
Organization: Credence Research
Address: 105 N 1st ST #429, SAN JOSE,, CA 95103, United States
Phone: 18003618290
Website: https://www.credenceresearch.com/report/insomnia-treatment-drugs-market

Release ID: 451874